Cargando…
Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
BACKGROUND: Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575247/ https://www.ncbi.nlm.nih.gov/pubmed/23339583 http://dx.doi.org/10.1186/1742-4933-10-2 |
_version_ | 1782259681434009600 |
---|---|
author | Vianello, Elena Dogliotti, Giada Dozio, Elena Romanelli, Massimiliano Marco Corsi |
author_facet | Vianello, Elena Dogliotti, Giada Dozio, Elena Romanelli, Massimiliano Marco Corsi |
author_sort | Vianello, Elena |
collection | PubMed |
description | BACKGROUND: Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect are not well known. Since heart-type fatty acid binding protein (H-FABP) is a protein involved in the transport of fatty acids and it has been recently correlated with the presence of atherosclerosis, we aimed to measure H-FABP level both in DS and in healthy subjects during aging to evaluate the association between this molecule, aging and atherosclerosis. FINDINGS: We quantified plasmatic H-FABP level in three groups of male DS and age-matched healthy subjects (children, age 2–14 years; adults, age 20–50 years; elderly, > 60 years) using a biochip array analyzer. We observed that aging is associated with increased H-FABP level in healthy subjects but not in DS which display both the same protein level in the different ages of life and have also lower level compared to their age-matched healthy subjects. CONCLUSION: Reduced H-FABP level during aging in DS may play a protective role against atherosclerosis. The potential involvement of H-FABP in the relationship between aging, atherosclerosis and development of coronary artery disease needs further investigations. |
format | Online Article Text |
id | pubmed-3575247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35752472013-02-19 Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis Vianello, Elena Dogliotti, Giada Dozio, Elena Romanelli, Massimiliano Marco Corsi Immun Ageing Short Report BACKGROUND: Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect are not well known. Since heart-type fatty acid binding protein (H-FABP) is a protein involved in the transport of fatty acids and it has been recently correlated with the presence of atherosclerosis, we aimed to measure H-FABP level both in DS and in healthy subjects during aging to evaluate the association between this molecule, aging and atherosclerosis. FINDINGS: We quantified plasmatic H-FABP level in three groups of male DS and age-matched healthy subjects (children, age 2–14 years; adults, age 20–50 years; elderly, > 60 years) using a biochip array analyzer. We observed that aging is associated with increased H-FABP level in healthy subjects but not in DS which display both the same protein level in the different ages of life and have also lower level compared to their age-matched healthy subjects. CONCLUSION: Reduced H-FABP level during aging in DS may play a protective role against atherosclerosis. The potential involvement of H-FABP in the relationship between aging, atherosclerosis and development of coronary artery disease needs further investigations. BioMed Central 2013-01-22 /pmc/articles/PMC3575247/ /pubmed/23339583 http://dx.doi.org/10.1186/1742-4933-10-2 Text en Copyright ©2013 Vianello et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Vianello, Elena Dogliotti, Giada Dozio, Elena Romanelli, Massimiliano Marco Corsi Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
title | Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
title_full | Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
title_fullStr | Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
title_full_unstemmed | Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
title_short | Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
title_sort | low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575247/ https://www.ncbi.nlm.nih.gov/pubmed/23339583 http://dx.doi.org/10.1186/1742-4933-10-2 |
work_keys_str_mv | AT vianelloelena lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis AT dogliottigiada lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis AT dozioelena lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis AT romanellimassimilianomarcocorsi lowhearttypefattyacidbindingproteinlevelduringagingmayprotectdownsyndromepeopleagainstatherosclerosis |